IGF ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER
Key facts
| Status | Awarded |
|---|---|
| Estimated value | $25,993,792.86 |
| Submission deadline | Deadline not published |
| Published | Aug 31, 2017 |
| Buyer | National Institutes of Health |
| Country | United States · PA |
| CPV code | NAICS 541712 (RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND L) · PSC AN12 |
| Source | USAspending.gov Federal Contract Awards ↗ |
- Status
- Awarded
- Estimated value
- $25,993,792.86
- Submission deadline
- Deadline not published
- Published
- Aug 31, 2017
- Country
- United States
- CPV code
- NAICS 541712 (RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND L) · PSC AN12
- Source
- USAspending.gov Federal Contract Awards
Contract outcome & evergreen alternatives
This notice is no longer open for submissions. The original remains available for reference.
| Awarded supplier / winner | Registration / LEI number | Country | Awarded contract amount | Award date |
|---|---|---|---|---|
| THOMAS JEFFERSON UNIVERSITY | US-UEI: R8JEVL4ULGB7 | United States | $25,993,792.86 | Aug 31, 2017 |
Checked:
The original notice takes precedence. Its status and conditions can change after collection.
Description
IGF ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER
Awarding Agency: Department of Health and Human Services — National Institutes of Health.
NAICS 541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY).
PSC AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Period of Performance: 2017-08-31 to 2028-01-31.